Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
Case 3: retreating after BTK intolerance
For patients intolerant of ibrutinib, she considers pirtobrutinib or switching to more selective covalent BTKIs depending on history.
Play episode from 32:42
Transcript
